Rajendra Prasad S*, Rusheeka Pulluri, Mounika B, Sunil Kumar B, Suchitra Reddy K, P Gandiah and K Sumanth Kumar
Department of General Medicine, SVS Medical College, India
*Corresponding Author: Rajendra Prasad S, Department of General Medicine, SVS Medical College, India.
Received: May 02, 2022; Published: May 23, 2022
The WHO has declared the COVID-19 outbreak a Public Health Emergency of International Concern on 30th January, 2020, and a pandemic on 11th March, 2020. Cases have been reported in 226 countries and territories around the world. More than 517 million people worldwide have been infected so far, with a global mortality rate of approximately 1.2%. The causative agent is a virus designated the SARS-CoV-2. It was initially thought to be solely a respiratory pathogen, however, many observational studies and case reports have documented a high rate of multisystem complications associated with COVID-19. There is growing evidence that SARS‐CoV2 infection could be associated with various neurological complications as well, including but not limited to - headache, dizziness, febrile seizures, encephalitis, encephalopathy, stroke, and acute peripheral nerve diseases. Amongst all the observed neurological manifestations occurring in COVID-19 infected individuals, the commonest ones are ischemic stroke, Guillain-Barré Syndrome (GBS), and hypoxic encephalopathy.
Keywords: COVID-19; SARS‐CoV2; WHO
Citation: Rajendra Prasad S., et al. “Guillain Barré Syndrome Associated with Covid-19: A Case Report". Acta Scientific Clinical Case Reports 3.6 (2022): 57-59.
Copyright: © 2022 Rajendra Prasad S., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.